![David N. Bell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
David N.
Bell worked as the Chief Scientific Officer & VP-Drug Development at Therapure Biopharma, Inc. from 2007 to 2020.
Prior to that, he was the Vice President-Drug Development & Research at 1608557 Ontario, Inc. He received a graduate degree from McGill University and a doctorate in 1988 from the same institution.
Eerdere bekende functies van David N. Bell
| Bedrijven | Functie | Einde |
|---|---|---|
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology Develops and manufacturers biologics, particularly blood-related based therapeutics | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van David N. Bell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
98
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
1608557 Ontario, Inc.
1608557 Ontario, Inc. BiotechnologyHealth Technology Develops and manufacturers biologics, particularly blood-related based therapeutics | Health Technology |
Kies MarketScreener 
